Natriumchlorid Fresenius (Sodium Chloride)

Sodium Chloride, the active ingredient in Natriumchlorid Fresenius, is an electrolyte presented as an injection solution for intravenous use. It restores extracellular sodium and chloride concentrations and expands plasma volume, aiding fluid replacement and electrolyte balance in patients with hypovolemia or hyponatremia.

GNH USA supplies Natriumchlorid Fresenius as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and oncology centres worldwide.

Natriumchlorid Fresenius, an intravenous sodium chloride solution, is used in fluid and electrolyte replacement therapy.

- Fluid replacement: restores intravascular volume in patients with blood loss or dehydration. - Electrolyte replenishment: corrects sodium and chloride deficits. - Hyponatremia: raises low serum sodium levels. - Hypovolemia: expands plasma volume to improve circulatory stability.

Adverse reactions may occur with intravenous sodium chloride administration.

Common Side Effects: - Injection site pain: discomfort at the infusion site. - Phlebitis: inflammation of the vein. - Hypernatremia: elevated serum sodium. - Hyperchloremia: elevated serum chloride. - Fluid overload: excess extracellular fluid. - Electrolyte imbalance: disturbances in other electrolytes.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response. - Severe hypervolemia: dangerous fluid excess. - Metabolic acidosis: significant pH shift. - Cardiac arrhythmia: abnormal heart rhythm.

When using Natriumchlorid Fresenius, clinicians should observe several safety measures.

- Monitor serum electrolytes: check sodium and chloride levels regularly. - Assess fluid status: avoid use in patients with existing fluid overload. - Use caution in renal impairment: adjust volume as needed. - Avoid rapid infusion: follow recommended infusion rates. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Intravenous sodium chloride can interact with other therapies; awareness of major and moderate interactions helps ensure safe use.

Major Interactions (Avoid): - Concomitant hypertonic saline: risk of severe hypernatremia. - Loop diuretics: may exacerbate electrolyte shifts.

Moderate Interactions (Monitor Closely): - Corticosteroids: may affect fluid balance. - Vasopressors: may require dose adjustments. - Anticoagulants: volume changes can influence bleeding risk.